机构:[1]School of Medicine, University of Electronic Science and Technology of China, Chengdu 611731, Sichuan Province, China四川省人民医院[2]Department of Pathology, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu 610041, Sichuan Province, China四川省人民医院四川省肿瘤医院[3]Personalized Drug Therapy Key Laboratory of Sichuan Province, Sichuan Academy of Medical Sciences and Sichuan Provincial People’s Hospital, Chengdu 610072, Sichuan Province, China四川省人民医院[4]Radiation Therapy Center, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu 610041, Sichuan Province, China四川省人民医院四川省肿瘤医院
Neoadjuvant chemoradiotherapy (nCRT) and total rectal mesenteric excision are the main standards of treatment for locally advanced rectal cancer (LARC). Lymph node regression grade (LRG) is an indicator of prognosis and response to preoperative nCRT based on postsurgical metastatic lymph node pathology. Common histopathological findings in metastatic lymph nodes after nCRT include necrosis, hemorrhage, nodular fibrosis, foamy histiocytes, cystic cell reactions, areas of hyalinosis, residual cancer cells, and pools of mucin. A number of LRG systems designed to classify the amount of lymph node regression after nCRT is mainly concerned with the relationship between residual cancer cells and regressive fibrosis and with estimating the number of lymph nodes existing with residual cancer cells. LRG offers significant prognostic information, and in most cases, LRG after nCRT correlates with patient outcomes. In this review, we describe the systematic classification of LRG after nCRT, patient prognosis, the correlation with tumor regression grade, and the typical histopathological findings of lymph nodes. This work may serve as a reference to help predict the clinical complete response and determine lymph node regression in patients based on preservation strategies, allowing for the formulation of more accurate treatment strategies for LARC patients, which has important clinical significance and scientific value.
基金:
Chengdu Science and Technology Project [2021-YF05-01484-SN]; Excellent Youth Foundation Project of Sichuan Cancer Hospital [YB2021037]; Foundation Project of Health Commission of Sichuan Province [20PJ112]
第一作者机构:[1]School of Medicine, University of Electronic Science and Technology of China, Chengdu 611731, Sichuan Province, China
通讯作者:
通讯机构:[4]Radiation Therapy Center, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu 610041, Sichuan Province, China[*1]Radiation Therapy Center, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, No. 55 Section 4, Renmin South Road, Chengdu 610041, Sichuan Province, China.
推荐引用方式(GB/T 7714):
He Lei,Xiao Juan,Zheng Ping,et al.Lymph node regression grading of locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy[J].WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY.2022,14(8):1429-1445.doi:10.4251/wjgo.v14.i8.1429.
APA:
He, Lei,Xiao, Juan,Zheng, Ping,Zhong, Lei&Peng, Qian.(2022).Lymph node regression grading of locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy.WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY,14,(8)
MLA:
He, Lei,et al."Lymph node regression grading of locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy".WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY 14..8(2022):1429-1445